Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2019-03-20 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于监事会完成换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the completion of the supervisory board election at the company 嘉事堂药业股份有限公司. It details the election results, qualifications of the new supervisory board members, and compliance with relevant laws and regulations. There is no financial data, no mention of a report being attached or published, and no indication of a full report or detailed financial statements. The content is about board/management changes specifically related to the supervisory board election. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report publication.
2019-03-20 Chinese
关于董事会完成换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of the board of directors' re-election at the 2018 annual shareholders meeting. It details the election results of non-independent and independent directors, their qualifications, and compliance with relevant laws and regulations. The document does not contain financial statements or detailed financial performance data. It is a formal announcement about changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is short (1021 characters), and it is not a report or presentation but an official announcement of board changes.
2019-03-20 Chinese
关于使用闲置募集资金暂时补充流动资金的公告（更新后）
Capital/Financing Update Classification · 95% confidence The document is an announcement from 嘉事堂药业股份有限公司 regarding the temporary use of idle raised funds to supplement working capital. It details the approval process by the board and supervisory committee, references regulatory compliance with the China Securities Regulatory Commission, and includes financial figures related to the use of raised funds. The document is relatively short (4157 characters) and primarily serves as a formal disclosure of a financing activity related to the use of capital raised from a previous non-public stock issuance. It does not contain comprehensive financial statements or detailed financial performance data, nor is it a transcript, report, or presentation. The content fits best under Capital/Financing Update (CAP) as it updates on the company's use of raised capital and financing activities.
2019-03-14 Chinese
关于使用闲置募集资金暂时补充流动资金的补充更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement regarding the use of idle raised funds temporarily supplementing working capital by the company 嘉事堂药业股份有限公司. It is a short announcement (903 characters) correcting a previous announcement about the use of raised funds. There is no financial data, no detailed report, no financial statements, or comprehensive analysis. It is not an annual or interim report, nor an earnings release. It is a regulatory announcement correcting a prior disclosure related to capital use. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-03-14 Chinese
前次募集资金使用情况鉴证报告（2018年12月31日）
Audit Report / Information Classification · 95% confidence The document is titled '前次募集资金使用情况鉴证报告' which translates to 'Verification Report on the Use of Previous Fundraising Proceeds'. It includes detailed financial data and analysis about the use of funds raised through a non-public stock issuance, including amounts raised, usage, investment projects, and economic benefits realized. The document references regulatory requirements from the China Securities Regulatory Commission and includes an auditor's verification opinion. The content is substantive and detailed, not merely an announcement or certification. This type of report is a standalone audit or verification report on the use of fundraising proceeds, which fits the category of Audit Report / Information (AR). It is not an Annual Report, Interim Report, or Earnings Release, nor is it a simple announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2018
2019-03-13 Chinese
独立董事关于公司第五届董事会第三十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on a specific board meeting matter regarding the temporary use of idle raised funds to supplement working capital. It references compliance with company articles, regulatory guidelines, and internal procedures. The content is a formal opinion statement by independent directors rather than a full financial report or announcement of voting results. It is not a full Annual Report, Audit Report, or Earnings Release. It is also not a regulatory filing or certification letter. The document is related to board/management information as it concerns board meeting matters and independent directors' opinions on company financial decisions. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length and content support this classification with high confidence.
2019-03-13 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.